Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andres Matoso

Showing results (131-140 of 182) with videos related to

Pageof 19
Sort By:
Urologic Oncology|January 20, 2022
Residual CIS after neoadjuvant chemotherapy and radical cystectomy for muscle invasive bladder cancer: Implications for neoadjuvant trialsAndrew T Gabrielson, Marcus J Daniels, Julian Rowe, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 29, 2020
Urothelial Carcinoma In Situ of the Bladder: Correlation of CK20 Expression With Adaptive Immune Resistance, Response to BCG Therapy, and Clinical OutcomeKara A Lombardo, Belkiss Murati Amador, Vamsi Parimi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 16, 2022
Molecular assessment of paratesticular rhabdomyomas demonstrates recurrent findings, including a novel H3C2 p.K37I mutationAndres M Acosta, Jesse K McKenney, Lynette M Sholl, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 26, 2021
Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial HistotypesJean H Hoffman-Censits, Kara A Lombardo, Vamsi Parimi, et al.
Histopathology|February 8, 2023
Comparison of clinicopathological characteristics, gene expression profiles, mutational analysis, and clinical outcomes of pure and mixed small-cell carcinoma of the bladderVamsi Parimi, Woonyoung Choi, Mingxiao Feng, et al.
The Journal of Clinical Investigation|December 4, 2024
YAP1 induces bladder cancer progression and promotes immune evasion through IL-6/STAT3 pathway and CXCL deregulationPritam Sadhukhan, Mingxiao Feng, Emily Illingworth, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 22, 2011
Expression of S100A4 in renal epithelial neoplasmsLi J Wang, Andres Matoso, Katherine T Sciandra, et al.
The American Journal of Surgical Pathology|July 6, 2018
Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations: Molecular Analysis Supports an Expanding Clinicopathologic SpectrumDoreen N Palsgrove, Yunjie Li, Christine A Pratilas, et al.
European Urology|September 29, 2023
Reply to Kentaro Inamura's Letter to the Editor re: Mingxiao Feng, Andres Matoso, Gabriel Epstein, et al. Identification of Lineage-specific Transcriptional Factor-defined Molecular Subtypes in Small Cell Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.05.023Mingxiao Feng, Andres Matoso, Gabriel Epstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Frequent downregulation of miR-34 family in human ovarian cancersDavid C Corney, Chang-Il Hwang, Andres Matoso, et al.
Pageof 19

Showing results (131-140 of 182) with videos related to

Sort By:
Pageof 19
Urologic Oncology|January 20, 2022
Residual CIS after neoadjuvant chemotherapy and radical cystectomy for muscle invasive bladder cancer: Implications for neoadjuvant trialsAndrew T Gabrielson, Marcus J Daniels, Julian Rowe, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 29, 2020
Urothelial Carcinoma In Situ of the Bladder: Correlation of CK20 Expression With Adaptive Immune Resistance, Response to BCG Therapy, and Clinical OutcomeKara A Lombardo, Belkiss Murati Amador, Vamsi Parimi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 16, 2022
Molecular assessment of paratesticular rhabdomyomas demonstrates recurrent findings, including a novel H3C2 p.K37I mutationAndres M Acosta, Jesse K McKenney, Lynette M Sholl, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 26, 2021
Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial HistotypesJean H Hoffman-Censits, Kara A Lombardo, Vamsi Parimi, et al.
Histopathology|February 8, 2023
Comparison of clinicopathological characteristics, gene expression profiles, mutational analysis, and clinical outcomes of pure and mixed small-cell carcinoma of the bladderVamsi Parimi, Woonyoung Choi, Mingxiao Feng, et al.
The Journal of Clinical Investigation|December 4, 2024
YAP1 induces bladder cancer progression and promotes immune evasion through IL-6/STAT3 pathway and CXCL deregulationPritam Sadhukhan, Mingxiao Feng, Emily Illingworth, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 22, 2011
Expression of S100A4 in renal epithelial neoplasmsLi J Wang, Andres Matoso, Katherine T Sciandra, et al.
The American Journal of Surgical Pathology|July 6, 2018
Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations: Molecular Analysis Supports an Expanding Clinicopathologic SpectrumDoreen N Palsgrove, Yunjie Li, Christine A Pratilas, et al.
European Urology|September 29, 2023
Reply to Kentaro Inamura's Letter to the Editor re: Mingxiao Feng, Andres Matoso, Gabriel Epstein, et al. Identification of Lineage-specific Transcriptional Factor-defined Molecular Subtypes in Small Cell Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.05.023Mingxiao Feng, Andres Matoso, Gabriel Epstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Frequent downregulation of miR-34 family in human ovarian cancersDavid C Corney, Chang-Il Hwang, Andres Matoso, et al.
Pageof 19